top of page
Image by Markus Winkler

What We Hear

Latest Oncology News and other Resources

What is CAR-T cell therapy?

August 20, 2020

Should cancer patients get a COVID-19 vaccine?

February 15, 2021

Why get a second opinion when you are diagnosed with cancer?

February 27, 2021

Should I have herb and supplements while I am having cancer treatments?

March 3, 2021

Approval of lisocabtagene maraleucel (Breyanzi) for the patients with large B-cell lymphomas

March 5, 2021

FDA approves axicabtagene ciloleucel (escarta) for the treatment of the patients with follicular lymphoma

March 5, 2021

FDA approves the first CAR-T cell therapy, idecabtagene vicleucel for the multiple myeloma patients

March 29, 2021

What is difference between chemotherapy and targeted therapy?

March 30, 2021

What are immune checkpoint inhibitors?

April 10, 2021

The FDA approves sacituzumab govitecan (TRODELVY) the patients with metastatic triple-negative breast cancer and metastatic urothelial carcinoma

April 13, 2021

Datopotamab deruxtecan shows promising results for the patients with triple-negative breast cancer

May 12, 2021

Personalized treatment strategy is beneficial for the survival of metastatic gastroesophageal cancer patients

May 13, 2021

The FDA has granted an accelerated approval to amivantamab-vmjw (Rybrevant) for the patients with luing cancer

May 24, 2021

The first KRAS inhibitor, sotorasib (Lumakras)

May 31, 2021

The FDA has issued an alert regarding melphalan flufenamide (Pepaxto)

July 29, 2021

The importance of genetic testing in lung cancer

August 23, 2021

Promising new treatment for glioblastoma multiforme (GBM) and other malignant gliomas

September 3, 2021

FDA has granted the breakthrough device designation to Datar’s TriNetra Prostate Blood Test

February 14, 2022

Trastuzumab deruxtecan (Enhertu) continuously shows its superior efficacy as a treatment of breast cancer

February 23, 2022

What is a liquid biopsy and what does it do?

March 21, 2022

Cancer Patients and COVID-19 mRNA Vaccines: What to Know

April 12, 2022

Colorectal cancer incidence is rising among young adults

April 12, 2022

FDA has granted an accelerated approval to tisagenlecleucel (Kymriah) for follicular lymphoma patients

June 3, 2022

CAR-T cell therapy is also effective to treat cancer in Black and Hispanic patients

June 3, 2022

Trastuzumab deruxtecan (Enhertu) is efficacious to treat patients with hormone receptor-positive and HER2- low metastatic breast cancer

June 6, 2022

An immune-checkpoint inhibitor, dostarlimab-gxly (Jemperli) vanishes any signs of rectal cancer in all patients in a clinical trial

June 7, 2022

Black women are more likely to die from cervical cancer than White women

June 23, 2022

A new cancer vaccine therapy, VBI-1901 was granted orphan drug designation by FDA

June 25, 2022

More women are diagnosed with lung cancer than men!

July 6, 2022

Durvalumab improves survival of patients with limited-stage small cell lung cancer

June 27, 2024

©2023 by MJ Cancer Patient Advocacy Group

bottom of page